Literature DB >> 28687876

Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.

P N Alexandrov1, M E Percy2,3,4, Walter J Lukiw5,6,7.   

Abstract

Down's syndrome (DS; also known as trisomy 21; T21) is caused by a triplication of all or part of human chromosome 21 (chr21). DS is the most common genetic cause of intellectual disability attributable to a naturally-occurring imbalance in gene dosage. DS incurs huge medical, healthcare, and socioeconomic costs, and there are as yet no effective treatments for this incapacitating human neurogenetic disorder. There is a remarkably wide variability in the 'phenotypic spectrum' associated with DS; the progression of symptoms and the age of DS onset fluctuate, and there is further variability in the biophysical nature of the chr21 duplication. Besides the cognitive disruptions and dementia in DS patients other serious health problems such as atherosclerosis, altered lipogenesis, Alzheimer's disease, amyotrophic lateral sclerosis (Lou Gehrig's disease), autoimmune disease, various cancers including lymphoma, leukemia, glioma and glioblastoma, status epilepticus, congenital heart disease, hypotonia, manic depression, prostate cancer, Usher syndrome, motor disorders, Hirschsprung disease, and various physical anomalies such as early aging occur at elevated frequencies, and all are part of the DS 'phenotypic spectrum.' This communication will review the genetic link between these fore-mentioned diseases and a small group of just five stress-associated microRNAs (miRNAs)-that include let-7c, miRNA-99a, miRNA-125b, miRNA-155, and miRNA-802-encoded and clustered on the long arm of human chr21 and spanning the chr21q21.1-chr21q21.3 region.

Entities:  

Keywords:  42 Amino acid amyloid-beta (Aβ42) peptide; Alzheimer’s disease (AD); Down’s syndrome; MicroRNA (miRNA); Small non-coding RNAs (sncRNAs); Systemic inflammation

Mesh:

Substances:

Year:  2017        PMID: 28687876      PMCID: PMC5756687          DOI: 10.1007/s10571-017-0514-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  56 in total

1.  Reflex seizures in a patient with Angelman syndrome and trisomy 21.

Authors:  Edoardo Ferlazzo; Chiara Sueri; Maurizio Elia; Tiziana D'Agostino; Umberto Aguglia
Journal:  Neurol Sci       Date:  2016-03-14       Impact factor: 3.307

2.  miRNA-155 upregulation and complement factor H deficits in Down's syndrome.

Authors:  Yuan Y Li; Peter N Alexandrov; Aileen I Pogue; Yuhai Zhao; Surjyadipta Bhattacharjee; Walter J Lukiw
Journal:  Neuroreport       Date:  2012-02-15       Impact factor: 1.837

3.  Elevated Serum MicroRNA Let-7c in Moyamoya Disease.

Authors:  Shaoyun Zhao; Zhe Gong; Jing Zhang; Xiaoge Xu; Peidong Liu; Wenjuan Guan; Lijun Jing; Tao Peng; Junfang Teng; Yanjie Jia
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-06-10       Impact factor: 2.136

4.  MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.

Authors:  Hou-Gang Huang; Xi Luo; Shuai Wu; Bin Jian
Journal:  Asian Pac J Cancer Prev       Date:  2015

5.  Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.

Authors:  Bo Hou; Hajime Ishinaga; Kaoru Midorikawa; Said Ahmad Shah; Satoshi Nakamura; Yusuke Hiraku; Shinji Oikawa; Mariko Murata; Kazuhiko Takeuchi
Journal:  Cancer Biol Ther       Date:  2015-05-07       Impact factor: 4.742

Review 6.  Oxidative stress and pro-inflammatory cytokines may act as one of the signals for regulating microRNAs expression in Alzheimer's disease.

Authors:  Kedar N Prasad
Journal:  Mech Ageing Dev       Date:  2016-12-10       Impact factor: 5.432

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  The acquisition of cancer stem cell-like properties and neoplastic transformation of human keratinocytes induced by arsenite involves epigenetic silencing of let-7c via Ras/NF-κB.

Authors:  Rongrong Jiang; Yuan Li; Aihua Zhang; Bairu Wang; Yuan Xu; Wenchao Xu; Yue Zhao; Fei Luo; Qizhan Liu
Journal:  Toxicol Lett       Date:  2014-04-02       Impact factor: 4.372

Review 9.  "Down syndrome: an insight of the disease".

Authors:  Ambreen Asim; Ashok Kumar; Srinivasan Muthuswamy; Shalu Jain; Sarita Agarwal
Journal:  J Biomed Sci       Date:  2015-06-11       Impact factor: 8.410

10.  MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and Fragile X syndrome.

Authors:  Wei-Hong Siew; Kai-Leng Tan; Maryam Abbaspour Babaei; Pike-See Cheah; King-Hwa Ling
Journal:  Front Cell Neurosci       Date:  2013-04-15       Impact factor: 5.505

View more
  11 in total

1.  Down syndrome and microRNAs.

Authors:  Aldina Brás; António S Rodrigues; Bruno Gomes; José Rueff
Journal:  Biomed Rep       Date:  2017-11-17

2.  A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down's syndrome (DS; trisomy 21).

Authors:  Yuhai Zhao; Vivian Jaber; Maire E Percy; Walter J Lukiw
Journal:  J Nat Sci       Date:  2017-09

Review 3.  Clinical and biological aspects of myeloid leukemia in Down syndrome.

Authors:  Austin C Boucher; Kenneth J Caldwell; John D Crispino; Jamie E Flerlage
Journal:  Leukemia       Date:  2021-09-13       Impact factor: 12.883

Review 4.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

5.  Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21.

Authors:  Maria Chiara Pelleri; Elena Cicchini; Michael B Petersen; Lisbeth Tranebjaerg; Teresa Mattina; Pamela Magini; Francesca Antonaros; Maria Caracausi; Lorenza Vitale; Chiara Locatelli; Marco Seri; Pierluigi Strippoli; Allison Piovesan; Guido Cocchi
Journal:  Mol Genet Genomic Med       Date:  2019-06-25       Impact factor: 2.183

Review 6.  Autoimmunity and Genetic Syndromes: A Focus on Down Syndrome.

Authors:  Marta Ferrari; Stefano Stagi
Journal:  Genes (Basel)       Date:  2021-02-13       Impact factor: 4.096

Review 7.  Down syndrome and type I interferon: not so simple.

Authors:  Louise Malle; Dusan Bogunovic
Journal:  Curr Opin Immunol       Date:  2021-06-23       Impact factor: 7.268

Review 8.  Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis.

Authors:  Daniel W Nixon
Journal:  Brain Sci       Date:  2018-03-24

9.  Differential microRNA expression profile in blood of children with Down syndrome suggests a role in immunological dysfunction.

Authors:  Joice Matos Biselli; Bruna Lancia Zampieri; Patrícia Matos Biselli-Chicote; Jorge Estefano Santana de Souza; Matheus Carvalho Bürger; Wilson Araújo da Silva; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Hum Cell       Date:  2022-01-20       Impact factor: 4.374

Review 10.  Acute Megakaryocytic Leukemia.

Authors:  Maureen McNulty; John D Crispino
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.